IL15RA Drives Antagonistic Mechanisms of Cancer Development and Immune Control in Lymphocyte-Enriched Triple-Negative Breast CancersPierfrancesco Marra, Andrew Tutt, Sumi Mathew et al.|Cancer Research|2014Cited by 61
Bayesian clinical classification from high-dimensional data: Signatures versus variabilityAkram Shalabi, Anthony CC Coolen, Masato Inoue et al.|Statistical Methods in Medical Research|2016Cited by 10
Data Supplement from IL15RA Drives Antagonistic Mechanisms of Cancer Development and Immune Control in Lymphocyte-Enriched Triple-Negative Breast CancersPierfrancesco Marra, Andrew Tutt, Sumi Mathew et al.|Unknown|2023Cited by 0
Data Supplement from IL15RA Drives Antagonistic Mechanisms of Cancer Development and Immune Control in Lymphocyte-Enriched Triple-Negative Breast CancersPierfrancesco Marra, Andrew Tutt, Sumi Mathew et al.|Unknown|2023Cited by 0
Data Supplement from IL15RA Drives Antagonistic Mechanisms of Cancer Development and Immune Control in Lymphocyte-Enriched Triple-Negative Breast CancersPierfrancesco Marra, Andrew Tutt, Sumi Mathew et al.|Unknown|2023Cited by 0